Qingdao Baheal Medical INC. (SHE: 301015)

Qingdao Baheal Medical INC. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,180	1,180	1,048	1,276	1,107	1,163
Trading Asset Securities	27.62	27.62	27.22	40.77	34.9	-
Cash & Short-Term Investments	1,208	1,208	1,075	1,317	1,142	1,163
Cash Growth	12.33%	12.33%	-18.38%	15.32%	-1.79%	45.86%
Accounts Receivable	2,338	2,338	2,232	1,943	1,626	1,207
Other Receivables	33.6	33.6	44.43	41.34	43.35	31.01
Receivables	2,371	2,371	2,277	1,984	1,670	1,238
Inventory	684.57	684.57	650.1	623.85	610.35	487.13
Prepaid Expenses	-	-	0.6	0.55	1.01	0.16
Other Current Assets	190.38	190.38	255.48	165.91	118.2	93.56
Total Current Assets	4,454	4,454	4,258	4,092	3,541	2,981
Property, Plant & Equipment	395.27	395.27	432.99	225.75	170.71	173.58
Long-Term Investments	262.88	262.88	181.57	151.71	132.7	123.94
Goodwill	0.69	0.69	0.69	5.96	5.96	5.93
Other Intangible Assets	104.64	104.64	56.77	28.65	31.06	32.78
Long-Term Deferred Tax Assets	45.64	45.64	36.65	32.85	38.22	36.64
Long-Term Deferred Charges	34.31	34.31	8.01	8.3	14.12	6.15
Other Long-Term Assets	1.43	1.43	55.61	58.02	66.77	69.81
Total Assets	5,299	5,299	5,030	4,603	4,001	3,430
Accounts Payable	909.16	909.16	990.3	845.76	842.89	756.38
Accrued Expenses	98.58	98.58	211.14	138.26	98.84	96.49
Short-Term Debt	461.89	461.89	1,165	1,189	1,350	1,163
Current Portion of Long-Term Debt	19.35	19.35	-	-	-	-
Current Portion of Leases	-	-	27.34	15.42	-	-
Current Income Taxes Payable	110.99	110.99	33.99	32.52	38.26	19.44
Current Unearned Revenue	92.19	92.19	92.48	113.78	109.34	-
Other Current Liabilities	126.72	126.72	83.54	66.32	57.91	85.38
Total Current Liabilities	1,819	1,819	2,604	2,401	2,497	2,120
Long-Term Debt	726.26	726.26	-	-	-	-
Long-Term Leases	82.17	82.17	145.34	22.21	-	-
Long-Term Deferred Tax Liabilities	29	29	1.13	5.85	4.94	4.17
Total Liabilities	2,656	2,656	2,750	2,429	2,502	2,125
Common Stock	525.61	525.61	525.1	525.1	472.5	472.5
Additional Paid-In Capital	421.69	421.69	411.61	418.31	208.21	201.45
Retained Earnings	1,620	1,620	1,364	1,212	790.19	607.25
Comprensive Income & Other	101.63	101.63	1.65	2.11	1	-0.47
Total Common Equity	2,668	2,668	2,302	2,157	1,472	1,281
Minority Interest	-26.18	-26.18	-22.11	16.76	26.83	24.73
Shareholders' Equity	2,642	2,642	2,280	2,174	1,499	1,305
Total Liabilities & Equity	5,299	5,299	5,030	4,603	4,001	3,430
Total Debt	1,290	1,290	1,338	1,226	1,350	1,163
Net Cash (Debt)	-82.15	-82.15	-262.71	90.77	-207.89	0.1
Net Cash Growth	-	-	-	-	-	-99.60%
Net Cash Per Share	-0.15	-0.15	-0.50	0.18	-0.44	0.00
Filing Date Shares Outstanding	524.96	524.96	525.1	525.1	525.1	472.5
Total Common Shares Outstanding	524.96	524.96	525.1	525.1	472.5	472.5
Working Capital	2,635	2,635	1,654	1,691	1,044	860.79
Book Value Per Share	5.08	5.08	4.38	4.11	3.12	2.71
Tangible Book Value	2,563	2,563	2,245	2,123	1,435	1,242
Tangible Book Value Per Share	4.88	4.88	4.27	4.04	3.04	2.63
Buildings	-	-	206.13	206.13	195.22	194.85
Machinery	-	-	91.2	78.02	64.04	55.27
Construction In Progress	-	-	80.5	8.78	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.